VSTM Verastem Inc

Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).

$1.25  0.00 (0.00%)
As of 05/23/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2012
Outstanding shares:  186,361,206
Average volume:  1,550,859
Market cap:   $232,951,508
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B4Z1Y92
Valuation   (See tab for details)
PE ratio:   -3.19
PB ratio:   3.20
PS ratio:   75.18
Return on equity:   -77.87%
Net income %:   -1,828.81%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy